Jiuzhitang Co., Ltd. (SHE:000989)

Market Cap	7.34B +2.7%
Revenue (ttm)	2.40B +14.3%
Net Income	271.01M +44.0%
EPS	0.32 +44.3%
Shares Out	846.28M
PE Ratio	27.08
Forward PE	n/a
Dividend	0.30 (3.50%)
Ex-Dividend Date	May 14, 2026

Volume	4,476,100
Average Volume	18,532,130
Open	8.74
Previous Close	8.67
Day's Range	8.50 - 8.74
52-Week Range	8.30 - 13.30
Beta	0.32
RSI	32.17
Earnings Date	Aug 24, 2026

About Jiuzhitang

Jiuzhitang Co., Ltd. provides traditional Chinese, chemical, biological, and health medicine products in China. It offers Shuxuetong injections, Angong Niuhuang pills, Tianma Gouteng granules, Danxi granules, and Compound Lipid-Reducing tablets for cardiovascular and neurological treatment; Nude Flower Zizhu tablets, Xiaojin pills, Guizhi Fuling pills, Buxue Shengru granules, and Zhixue Zhentong capsules for gynecological treatment; Houyan pills for ear, nose, and throat (ENT) diseases; Jianwei Yuyang tablets for digestion; and prescription dru...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1999
• Employees: 3,674
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000989

Financial Performance

In 2025, Jiuzhitang's revenue was 2.23 billion, a decrease of -5.99% compared to the previous year's 2.37 billion. Earnings were 222.60 million, an increase of 2.96%.